FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40562011000001107: Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Apr 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2212161000001110 Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2212171000001117 Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Is a Product containing precisely zinc sulfate monohydrate 125 milligram/1 each conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Is a Aactizinc true Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Has dispensed dose form Conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Has specific active ingredient Zinc sulfate monohydrate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) 90 tablet 3 x 30 tablets Has AMP True Aactizinc 125mg effervescent tablets (TriOn Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start